These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2873028)

  • 61. Fasting plus prandial insulin supplements improve insulin secretory ability in NIDDM subjects.
    Kawamori R; Bando K; Yamasaki Y; Kubota M; Watarai T; Iwama N; Shichiri M; Kamada T
    Diabetes Care; 1989; 12(10):680-5. PubMed ID: 2515048
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of plasma glucose, serum insulin, and C-peptide responses to three isocaloric breakfasts in non-insulin-dependent diabetic subjects.
    Colagiuri S; Miller JJ; Holliday JL; Phelan E
    Diabetes Care; 1986; 9(3):250-4. PubMed ID: 3525055
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Glyburide decreases insulin requirement, increases beta-cell response to mixed meal, and does not affect insulin sensitivity: effects of short- and long-term combined treatment in secondary failure to sulfonylurea.
    Gutniak M; Karlander SG; Efendić S
    Diabetes Care; 1987; 10(5):545-54. PubMed ID: 2890501
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Somatostatin secretion in diabetic rabbits.
    Wilson HK; Boyd AE; Bolton WE; Conaway HH
    Metabolism; 1982 May; 31(5):428-32. PubMed ID: 6123063
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
    Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
    J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans.
    Butler PC; Chou J; Carter WB; Wang YN; Bu BH; Chang D; Chang JK; Rizza RA
    Diabetes; 1990 Jun; 39(6):752-6. PubMed ID: 2189768
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Postprandial changes in plasma ketone body and carnitine levels in normal and non-insulin-dependent diabetic subjects.
    Okuda Y; Kawai K; Murayama Y; Yamashita K
    Endocrinol Jpn; 1987 Jun; 34(3):415-22. PubMed ID: 3308442
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hypersecretion of gastric somatostatin in spontaneously diabetic BB rats.
    Ruggere MD; Patel YC
    Diabetes; 1987 Jul; 36(7):849-52. PubMed ID: 2884158
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Dawn phenomenon: its frequency in non-insulin-dependent diabetic patients on conventional therapy.
    Atiea JA; Ryder RR; Vora J; Owens DR; Luzio SD; Williams S; Hayes TM
    Diabetes Care; 1987; 10(4):461-5. PubMed ID: 3304895
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Rates of noninsulin-mediated glucose uptake are elevated in type II diabetic subjects.
    Baron AD; Kolterman OG; Bell J; Mandarino LJ; Olefsky JM
    J Clin Invest; 1985 Nov; 76(5):1782-8. PubMed ID: 2865274
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Radioimmunoassay may overestimate insulin in non-insulin-dependent diabetics.
    Temple RC; Clark PM; Nagi DK; Schneider AE; Yudkin JS; Hales CN
    Clin Endocrinol (Oxf); 1990 Jun; 32(6):689-93. PubMed ID: 2200619
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of insulin on vascular tone and sympathetic nervous system in NIDDM.
    Tack CJ; Smits P; Willemsen JJ; Lenders JW; Thien T; Lutterman JA
    Diabetes; 1996 Jan; 45(1):15-22. PubMed ID: 8522054
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evidence for a role of free fatty acids in the regulation of somatostatin secretion in normal and alloxan diabetic dogs.
    Wasada T; Howard B; Dobbs RE; Unger RH
    J Clin Invest; 1980 Sep; 66(3):511-6. PubMed ID: 6105166
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Glycemic and insulinemic responses after ingestion of ethnic foods by NIDDM and healthy subjects.
    Indar-Brown K; Noreberg C; Madar Z
    Am J Clin Nutr; 1992 Jan; 55(1):89-95. PubMed ID: 1728824
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The diabetogenic action of somatostatin in healthy subjects and in maturity onset diabetics.
    Waldhäusl W; Bratusch-Marrain P; Dudczak R; Deutsch E
    J Clin Endocrinol Metab; 1977 May; 44(5):876-83. PubMed ID: 870515
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of source of dietary carbohydrate on plasma glucose and insulin responses to mixed meals in subjects with NIDDM.
    Coulston AM; Hollenbeck CB; Swislocki AL; Reaven GM
    Diabetes Care; 1987; 10(4):395-400. PubMed ID: 3304893
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of glipizide treatment on response to an infused glucose load in patients with NIDDM.
    Sheu WH; Jeng CY; Fuh MM; Chen YD; Reaven GM
    Diabetes Care; 1995 Dec; 18(12):1582-7. PubMed ID: 8722055
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The effects of sucrose, fructose, and high-fructose corn syrup meals on plasma glucose and insulin in non-insulin-dependent diabetic subjects.
    Akgün S; Ertel NH
    Diabetes Care; 1985; 8(3):279-83. PubMed ID: 3891268
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects.
    Suter SL; Nolan JJ; Wallace P; Gumbiner B; Olefsky JM
    Diabetes Care; 1992 Feb; 15(2):193-203. PubMed ID: 1547676
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dose-dependent inhibitory and non-inhibitory action of somatostatin on insulin release in rats.
    Schusdziarra V; Bender H; Torres A; Pfeiffer EF
    Regul Pept; 1982 Aug; 4(3):147-53. PubMed ID: 6127757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.